{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T21:04:59Z","timestamp":1779311099429,"version":"3.51.4"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,28]],"date-time":"2019-11-28T00:00:00Z","timestamp":1574899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2019,11,28]],"date-time":"2019-11-28T00:00:00Z","timestamp":1574899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Ther"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1007\/s40121-019-00277-2","type":"journal-article","created":{"date-parts":[[2019,11,27]],"date-time":"2019-11-27T22:02:49Z","timestamp":1574892169000},"page":"77-87","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Comparing the Outcomes of Ceftaroline Plus Vancomycin or Daptomycin Combination Therapy Versus Monotherapy in Adults with Complicated and Prolonged Methicillin-Resistant Staphylococcus Aureus Bacteremia Initially Treated with Supplemental Ceftaroline"],"prefix":"10.1007","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5726-3723","authenticated-orcid":false,"given":"Omar","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy N.","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thein","family":"Myint","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,11,28]]},"reference":[{"key":"277_CR1","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1093\/clinids\/9.5.891","volume":"9","author":"JM Mylotte","year":"1987","unstructured":"Mylotte JM, McDermott C, Spooner JA. Prospective study of 114 consecutive episodes of Staphylococcus aureus bacteremia. Rev Infect Dis. 1987;9:891.","journal-title":"Rev Infect Dis"},{"key":"277_CR2","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1086\/512627","volume":"28","author":"S Shurland","year":"2007","unstructured":"Shurland S, Zhan M, Bradham DD, Roghmann MC. Comparison of mortality risk associated with bacteremia due to methicillin-resistant and methicillin-susceptible Staphylococcus aureus. Infect Control Hosp Epidemiol. 2007;28:273.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"277_CR3","doi-asserted-by":"publisher","first-page":"3315","DOI":"10.1128\/AAC.00113-08","volume":"52","author":"TP Lodise","year":"2008","unstructured":"Lodise TP, Graves J, Evans A, Graffunder E, Helmecke M, Lomaestro BM, Stellrecht K. Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin. Antimicrob Agents Chemother. 2008;52:3315.","journal-title":"Antimicrob Agents Chemother"},{"key":"277_CR4","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1086\/519470","volume":"45","author":"MH Kollef","year":"2007","unstructured":"Kollef MH. Limitations of vancomycin in the management of resistant staphylococcal infections. Clin Infect Dis. 2007;45:191\u20135.","journal-title":"Clin Infect Dis"},{"key":"277_CR5","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1086\/533592","volume":"46","author":"G Sakoulas","year":"2008","unstructured":"Sakoulas G, Moellering RC. Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains. Clin Infect Dis. 2008;46:360\u20137.","journal-title":"Clin Infect Dis"},{"key":"277_CR6","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1086\/520655","volume":"45","author":"HW Boucher","year":"2007","unstructured":"Boucher HW, Sakoulas G. Perspectives on daptomycin resistance, with emphasis on resistance in Staphylococcus aureus. Clin Infect Dis. 2007;45:601\u20138.","journal-title":"Clin Infect Dis"},{"key":"277_CR7","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1086\/655827","volume":"51","author":"GR Corey","year":"2010","unstructured":"Corey GR, Wilcox M, Talbot GH, Friedland HD, Baculik T, Witherell GW, Critchley I, Das AF, Thye D. Integrated analysis of CANVAS 1 and 2: phase 3, multicenter, randomized, double-blind studies to evaluate the safety and efficacy of ceftaroline versus vancomycin plus aztreonam in complicated skin and skin-structure infection. Clin Infect Dis. 2010;51:641\u201350.","journal-title":"Clin Infect Dis"},{"key":"277_CR8","doi-asserted-by":"publisher","first-page":"201","DOI":"10.2146\/ajhp160006","volume":"74","author":"BP White","year":"2017","unstructured":"White BP, Barber KE, Stover KR. Ceftaroline for the treatment of methicillin-resistant Staphylococcus aureus bacteremia. Am J Health Syst Pharm. 2017;74:201\u20138.","journal-title":"Am J Health Syst Pharm"},{"key":"277_CR9","doi-asserted-by":"publisher","first-page":"ofx084","DOI":"10.1093\/ofid\/ofx084","volume":"4","author":"RA Cosimi","year":"2017","unstructured":"Cosimi RA, Beik N, Kubiak DW, Johnson JA. Ceftaroline for severe methicillin-resistant Staphylococcus aureus infections: a systematic review. Open Forum Infect Dis. 2017;4:ofx084.","journal-title":"Open Forum Infect Dis"},{"key":"277_CR10","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.clinthera.2016.12.005","volume":"39","author":"D Gritsenko","year":"2017","unstructured":"Gritsenko D, Fedorenko M, Ruhe JJ, Altshuler J. Combination therapy with vancomycin and ceftaroline for refractory methicillin-resistant Staphylococcus aureus bacteremia: a case series. Clin Ther. 2017;39:212\u20138.","journal-title":"Clin Ther"},{"key":"277_CR11","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1093\/jac\/dku322","volume":"70","author":"KE Barber","year":"2015","unstructured":"Barber KE, Rybak MJ, Sakoulas GJ. Vancomycin plus ceftaroline shows potent in vitro synergy and was successfully utilized to clear persistent daptomycin-non-susceptible MRSA bacteremia. J Antimicrob Chemother. 2015;70:311\u20133.","journal-title":"J Antimicrob Chemother"},{"key":"277_CR12","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1080\/23744235.2016.1277587","volume":"49","author":"I Shafiq","year":"2017","unstructured":"Shafiq I, Bulman ZP, Spitznogle SL, Osorio JE, Reilly IS, Lesse AJ, Parameswaran GI, Mergenhagen KA, Tsuji BT. A combination of ceftaroline and daptomycin has synergistic and bactericidal activity in vitro against daptomycin nonsusceptible methicillin-resistant Staphylococcus aureus (MRSA). Infect Dis (Lond). 2017;49:410\u20136.","journal-title":"Infect Dis (Lond)"},{"key":"277_CR13","volume-title":"Performance Standards for Antimicrobial Susceptibility Testing. Sixteenth informational supplement M100-S16","author":"Clinical and Laboratory Standards Institute\/NCCLS","year":"2006","unstructured":"Clinical and Laboratory Standards Institute\/NCCLS. Performance Standards for Antimicrobial Susceptibility Testing. Sixteenth informational supplement M100-S16. Wayne: CLSI; 2006."},{"key":"277_CR14","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1161\/CIR.0000000000000296","volume":"132","author":"LM Baddour","year":"2015","unstructured":"Baddour LM, Wilson WR, Bayer AS, Fowler VG, Tleyjeh IM, Rybak MJ, Barsic B, Lockhart PB, Gewitz MH, Levison ME, Bolger AF, Steckelberg JM, Baltimore RS, Fink AM, O\u2019Gara P, Taubert KA. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the american heart association. Circulation. 2015;132:1435.","journal-title":"Circulation"},{"key":"277_CR15","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373\u201383.","journal-title":"J Chronic Dis"},{"key":"277_CR16","doi-asserted-by":"publisher","first-page":"585","DOI":"10.7326\/0003-4819-115-8-585","volume":"115","author":"JW Chow","year":"1991","unstructured":"Chow JW, Fine MJ, Shlaes DM, Quinn JP, Hooper DC, Johnson MP, Ramphal R, Wagener MM, Miyashiro DK, Yu VL. Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med. 1991;115:585\u201390.","journal-title":"Ann Intern Med"},{"key":"277_CR17","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1093\/cid\/ciq146","volume":"52","author":"C Liu","year":"2011","unstructured":"Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, Kaplan SL, Karchmer AW, Levine DP, Murray BE, Rybak M, Talan DA, Chambers HF. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011;52:e18\u201355.","journal-title":"Clin Infect Dis"},{"key":"277_CR18","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.ijantimicag.2011.03.006","volume":"38","author":"G Wu","year":"2011","unstructured":"Wu G, Abraham T, Rapp J, Vastey F, Saad N, Balmir E. Daptomycin: evaluation of a high-dose treatment strategy. Int J Antimicrob Agents. 2011;38:192\u20136.","journal-title":"Int J Antimicrob Agents"},{"key":"277_CR19","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.ijantimicag.2010.07.011","volume":"36","author":"M Bassetti","year":"2010","unstructured":"Bassetti M, Nicco E, Ginocchio F, Ansaldi F, de Florentiis D, Viscoli C. High-dose daptomycin in documented Staphylococcus aureus infections. Int J Antimicrob Agents. 2010;36:459\u201361.","journal-title":"Int J Antimicrob Agents"},{"key":"277_CR20","unstructured":"Teflaro [package insert]. Saint Louis: Forest Pharmaceuticals; 2016."},{"key":"277_CR21","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1093\/jac\/dku378","volume":"70","author":"KE Barber","year":"2015","unstructured":"Barber KE, Werth BJ, Rybak MJ. The combination of ceftaroline plus daptomycin allows for therapeutic de-escalation and daptomycin sparing against MRSA. J Antimicrob Chemother. 2015;70:505\u20139.","journal-title":"J Antimicrob Chemother"},{"key":"277_CR22","first-page":"a2466","volume":"3","author":"C Duplessis","year":"2011","unstructured":"Duplessis C, Crum-Cianflone NF. Ceftaroline: a new cephalosporin with activity against methicillin-resistant Staphylococcus aureus (MRSA). Clin Med Rev Ther. 2011;3:a2466.","journal-title":"Clin Med Rev Ther"},{"key":"277_CR23","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1128\/CMR.05022-11","volume":"25","author":"SJ van Hal","year":"2012","unstructured":"van Hal SJ, Jensen SO, Vaska VL, Espedido BA, Paterson DL, Gosbell IB. Predictors of mortality in Staphylococcus aureus bacteremia. Clin Microbiol Rev. 2012;25:362\u201386.","journal-title":"Clin Microbiol Rev"},{"key":"277_CR24","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1093\/jac\/dkt016","volume":"68","author":"O Gasch","year":"2013","unstructured":"Gasch O, Camoez M, Dominguez MA, Padilla B, Pintado V, Almirante B, Lepe JA, Lagarde M, Ruiz de Gopegui E, Mart\u00ednez JA, Montejo M, Torre-Cisneros J, Arn\u00e1iz A, Goenaga MA, Benito N, Rodr\u00edguez-Ba\u00f1o J, Pujol M. Predictive factors for early mortality among patients with methicillin-resistant Staphylococcus aureus bacteremia. J Antimicrob Chemother. 2013;68:1423\u201330.","journal-title":"J Antimicrob Chemother"},{"key":"277_CR25","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3904\/kjim.2016.351","volume":"34","author":"T Kim","year":"2018","unstructured":"Kim T, Chong YP, Park KH, Bang KM, Park SJ, Kim SH, Jeong JY, Lee SO, Choi SH, Woo JH, Kim YS. Clinical and microbiological factors associated with early patient mortality from methicillin-resistant Staphylococcus aureus bacteremia. Korean J Intern Med. 2018;34:184\u201394.","journal-title":"Korean J Intern Med"},{"key":"277_CR26","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1001\/jama.2014.6364","volume":"312","author":"AC Kalil","year":"2014","unstructured":"Kalil AC, Van Schooneveld TC, Fey PD, Rupp ME. Association between vancomycin minimum inhibitory concentration and mortality among patients with Staphylococcus aureus bloodstream infections: a systematic review and meta-analysis. JAMA. 2014;312:1552\u201364.","journal-title":"JAMA"}],"container-title":["Infectious Diseases and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-019-00277-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40121-019-00277-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-019-00277-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T22:58:59Z","timestamp":1720047539000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40121-019-00277-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,28]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["277"],"URL":"https:\/\/doi.org\/10.1007\/s40121-019-00277-2","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.736999795.793587622","asserted-by":"object"}]},"ISSN":["2193-8229","2193-6382"],"issn-type":[{"value":"2193-8229","type":"print"},{"value":"2193-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,28]]},"assertion":[{"value":"11 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}